Team Internet is now firmly in a scaling phase - ICYMI
Team Internet Group PLC (AIM:TIG, OTCQX:TIGXF, FRA:4CN) this week outlined continued progress across its search, AI and international expansion initiatives,...
IMAX - IMAX Corporation
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$45.43
DETAILS
HIGH:
$60.00
LOW:
$34.00
MEDIAN:
$46.00
CONSENSUS:
$45.43
UPSIDE:
16.13%
Stock News
Metals One is a identifier, financier and developer - ICYMI
Metals One PLC (AIM:MET1, FRA:HT7, OTCQB:MTOPF) this week outlined progress across its gold and uranium project portfolio as chief executive Daniel Maling...
First Phosphate CEO discusses Agnico Eagle’s $94M move into phosphate market - ICYMI
First Phosphate Corp. (CSE:PHOS, OTCQX:FRSPF, FRA:KD0, OTC:FPHOY) CEO John Passalacqua talked with Proactive about the implications of Agnico Eagle Mines’...
OKYO Pharma expands scientific advisory board with cornea expert - ICYMI
OKYO Pharma Ltd (NASDAQ:OKYO) earlier this week announced the appointment of Dr. Marta Sacchetti to its scientific advisory board as the company advances...
Ilika advances Goliath commercialisation strategy - ICYMI
Ilika PLC (AIM:IKA, OTCQX:ILIKF, FRA:I8A) CEO, Graeme Purdy, talked with Proactive about the company’s latest commercial progress, including the first...
IMAX has bucked the trend as the movie-theater business fades — here's why it's so attractive to would-be buyers
The sale of the large-format movie chain could bring interest from tech firms, media companies and even sovereign wealth funds, analysts say
IMAX Might Be Exploring a Sale. Who Could Be Buying.
The Wall Street Journal reported that IMAX is exploring a sale and has approached entertainment companies as potential buyers.
Tiziana Life Sciences advances foralumab program with full Phase 2 enrollment and encouraging expanded access data – ICYMI
Tiziana Life Sciences Ltd (NASDAQ:TLSA) has completed enrollment in its Phase 2 clinical trial evaluating foralumab for secondary progressive multiple...
Wall Street thinks IMAX is ripe for a sale. Here's who could buy it
Shares of IMAX rose on Friday following speculation that the company is exploring a sale. A source familiar with the company told CNBC that IMAX has held "preliminary talks" through intermediaries, but no official pitches have been made by the company.
Dow Jones closes at new record high on Iran peace hopes
4:05pm: Dow at record high Hopes of a resolution to the Middle East conflict saw the Dow Jones finish at a record high 50,579 points, up 0.6%. The S&P 500...
IMAX shares post double-digit gain on sale speculation
IMAX Corp (NYSE:IMAX) is exploring a sale and has approached entertainment companies as potential buyers, the Wall Street Journal reported on Friday, sending shares of the premium cinema operator up 14.2%. The process is early and may not lead to a deal, according to the report.
Could Apple, Netflix or Amazon buy IMAX? shares rally 16%
Shares of IMAX jumped 16% on Friday after a report from The Wall Street Journal said the company is exploring a potential sale and has approached entertainment companies as possible buyers, fueling speculation that the premium cinema technology company could become an acquisition target for major media and technology firms. According to people familiar with the matter cited in the report, the sale process remains in its early stages and may not ultimately lead to a transaction.
Provaris Energy seeks to be an early mover in developing integrated green hydrogen projects
Deep Dive - Provaris Energy Ltd
Dow rises to record intraday high on Iran peace hopes
12:15pm: Consumer sentiment hits all-time low US consumer sentiment sank to a record low in May, with the University of Michigan’s index falling to 44.8...
EnWave is ramping up its unique Radiant Energy Vacuum dehydration technology
Deep Dive - EnWave Corp
Imax Exploring Sale, Has Held Preliminary Talks with Potential Suitors
Imax has held early stage talks with potential suitors of the large-screen exhibitor, Deadline has learned, confirming an initial report today in the Wall Street Journal.
IMAX has held ‘preliminary talks' with potential buyers, source says
Shares of IMAX jumped Thursday following a report that the company is exploring a sale. The premium theater company has held "preliminary talks" through intermediaries, a source familiar told CNBC, but no official pitches have been made by the company.
IMAX is exploring sale, WSJ reports
Cinema operator IMAX is exploring a sale and has approached entertainment companies as potential buyers, the Wall Street Journal reported on Thursday, citing people familiar with the matter.
IMAX Shares Pop On Reports It's Exploring A Sale
IMAX Corp. (NYSE:IMAX) is reportedly testing buyer interest, with the company approaching entertainment firms about a potential sale, though discussions remain early and may not lead to a transaction, according to The Wall Street Journal.
IMAX Is Exploring a Sale
The high-end movie screen company's search for a buyer comes as premium theatrical experiences are growing faster than the overall box office.
Price Targets
IMAX Corporation (IMAX) PT Raised to $60 at Benchmark on Reports Company Exploring Sale
$60.00
(was $38.37)
KBW
Imax price target raised to $46 from $42 at Barrington
$46.00
(was $35.15)
Barrington
Imax price target raised to $47 from $40 at Wells Fargo
$47.00
(was $37.42)
Wells Fargo
Imax price target raised to $46 from $39 at Wedbush
$46.00
(was $38.61)
Wedbush
Imax price target raised to $42 from $40 at Roth Capital
$42.00
(was $38.31)
Eric Handler
·
Roth Capital
Imax price target raised to $42 from $37 at Barrington
$42.00
(was $35.71)
Barrington
Imax price target raised to $43 from $42 at Seaport Research
$43.00
(was $35.47)
David Joyce
·
Seaport Global
Imax upgraded to Neutral from Sell at Goldman Sachs
$34.00
(was $36.00)
Goldman Sachs
Imax price target raised to $40 from $36 at Roth Capital
$40.00
(was $31.69)
Roth Capital
Imax price target raised to $37 from $32 at Barrington
$37.00
(was $32.30)
Barrington
Imax price target raised to $38 from $31 at Seaport Research
$38.00
(was $26.85)
David Joyce
·
Seaport Global
B.Riley Reiterates Buy Rating on IMAX Corporation (IMAX)
$30.00
(was $19.74)
Eric Wold
·
B.Riley Financial
These Analysts Boost Their Forecasts On Imax After Q2 Results
$25.00
(was $19.96)
James Goss
·
Barrington
These Analysts Boost Their Forecasts On Imax After Q2 Results
$24.00
(was $19.96)
Alicia Reese
·
Wedbush
IMAX Corporation (IMAX) PT Raised to $26 at Macquarie, 'remains one of our top small-cap Gaming/Lodging/Leisure picks'
$26.00
(was $20.09)
Chad Beynon
·
Macquarie
Imax initiated with a Buy at Seaport Research amid film release turnaround
$23.00
(was $17.75)
David Joyce
·
Seaport Global
Strong box office lineup in 2025-26 to reaccelerate Imax growth, says Roth MKM
$22.00
(was $15.41)
Eric Handler
·
Roth Capital
IMAX Secures Box Office Win With Dune Part 2: Analyst Predicts More High-Profile Projects And Global Expansion
$22.00
(was $16.79)
Alicia Reese
·
Wedbush
IMAX Analyst Bullish On Stock As Box Office Revenue Shows Strong Recovery
$24.00
(was $18.43)
James Goss
·
Barrington
IMAX Soars Following Upbeat Q2 Results: Analysts Bullish on Theatrical Rebound and Global Expansion
$26.00
(was $18.88)
Alicia Reese
·
Wedbush